NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

NEW YORK, Jan 31 (Reuters) - Mylan Laboratories Inc. said on Wednesday it was reorganizing its executive ranks after acquiring a controlling interest in India's Matrix Laboratories Ltd. , and that ...

A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat the opioid crisis across the nation. Under the tentative settlement, Mylan ...

TEL AVIV (MarketWatch) -- Mylan Laboratories Inc., the Pittsburgh pharmaceutical producer, said it definitively agreed to pay 4.9 billion euros, or about $6.7 billion, for the generic-drug operations ...

The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. Background Mylan petitioned for ...

Abbott Laboratories said it would sell a portion of its generics pharmaceuticals business to Mylan Inc. in an all-stock transaction valued at $5.3 billion that is the latest example of a health-care ...

PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

Mylan Pharmaceuticals Inc. recently filed an IPR petition, PTAB-IPR2023-00099, seeking cancellation of claims 1-3 of U.S. Patent No. 10,857,205, assigned to Regeneron Pharmaceuticals, Inc. According ...

NEW YORK (CBS.MW) - Mylan Labs reported fiscal first-quarter earnings of $82 million, or 30 cents a share, in line with year-earlier per share results. Excluding gains on legal settlements, earnings ...

How Parents Harnessed the Power of Social Media to Challenge EpiPen Prices A few vocal parents harnessed the power of Facebook and Twitter to pressure pharmaceutical firm Mylan to lower its price on ...

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100. By Jesus Jiménez The ...